🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

Recruitingn/aAges 18 Years - anyAllGERCOR - Multidisciplinary Oncology Cooperative G…
NCT04935853 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy, targeted therapy,loco-regional treatments ) in patients with bile duct cancer. The effectiveness and tolerance of these treatments in current practice will also be evaluated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All locations of primitives (intrahepatic CCA, extrahepatic CCA, adenocarcinoma of the gallbladder; ampullomas excluded) * Age \> 18 years * Diagnosed between 2003 and 2030 (minimum follow-up 2 years) * Written written non-opposition +/- signed informed consent for genetic studies (N.B.: exemption requested for a deceased patient) N.B. Authorized inclusion in a therapeutic research protocol Exclusion Criteria: * Patient under guardianship, curatorship or legal protection * Pregnant or breastfeeding women * Any medical, psychological or social situation, which could prevent the compliance with the protocol according to the investigator's assessment * Refusal to participate in the study
💊

What it tests

  • Not listed
📍

Where

32 sites
CHU Hôpital Sud Amiens
Amiens, France
CHU Angers
Angers, France
CHU Besançon
Besançon, France
Hôpital Avicenne
Bobigny, France
CHU - Henri Mondor
Créteil, France
CHU Dijon
Dijon, France
CHU Grenoble
Grenoble, France
CHU Lille
Lille, France

…and 24 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy